File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.schres.2011.09.006
- Scopus: eid_2-s2.0-81955167927
- PMID: 21968080
- WOS: WOS:000298512500005
- Find via
Supplementary
-
Bookmarks:
- CiteULike: 1
- Citations:
- Appears in Collections:
Article: Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study
Title | Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||||||||
Keywords | Course First-episode schizophrenia Outcome Persistent primary negative symptoms Stability | ||||||||||||||
Issue Date | 2011 | ||||||||||||||
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/schres | ||||||||||||||
Citation | Schizophrenia Research, 2011, v. 133 n. 1-3, p. 22-28 How to Cite? | ||||||||||||||
Abstract | Background: Negative symptoms are a core feature of schizophrenia. The evolution and trajectory of primary negative symptoms were under-studied. We aimed at evaluating the prevalence and stability of primary negative symptoms, and factors associated with persistent primary negative symptoms in a first-episode sample. Method: Ninety-three Hong Kong Chinese aged 18 to 55. years presenting with first-episode schizophrenia-spectrum disorder were studied. Data on premorbid adjustment, socio-demographics, and baseline clinical and cognitive profiles were obtained. Psychopathological and vocational reassessments were conducted at 12, 24 and 36. months. Primary negative symptoms were defined as the presence of clinically significant negative symptoms excluding depression and extra-pyramidal signs. Results: At baseline, 25.8% of subjects exhibited primary negative symptoms. A quarter of patients had their initial primary negative symptoms status retained 12. months after treatment initiation. In both Year 2 and Year 3 of study period, around 70% of subjects had their primary negative symptoms status maintained for 12. months. At the end of three-year follow-up, 23.7% were categorized as having persistent primary negative symptoms. Male sex, unemployment at intake, prolonged duration of untreated psychosis, poorer premorbid academic and social functioning, poorer insight and worse vocational outcome were found to be associated with persistent primary negative symptoms. Conclusion: Clinical status of primary negative symptoms in first-episode schizophrenia-spectrum disorder was unstable in the initial year of treatment. Baseline symptom assessment may not reliably predict development of persistent primary negative symptoms. Studying negative symptoms should take into account the longitudinal perspective, especially in the early course of psychotic disorders. © 2011 Elsevier B.V. | ||||||||||||||
Persistent Identifier | http://hdl.handle.net/10722/146905 | ||||||||||||||
ISSN | 2023 Impact Factor: 3.6 2023 SCImago Journal Rankings: 1.374 | ||||||||||||||
ISI Accession Number ID |
Funding Information: This work was supported by grant 21500.10202404 from the Research Grants Council of Hong Kong. | ||||||||||||||
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang, WC | en_HK |
dc.contributor.author | Hui, CLM | en_HK |
dc.contributor.author | Tang, JYM | en_HK |
dc.contributor.author | Wong, GHY | en_HK |
dc.contributor.author | Lam, MML | en_HK |
dc.contributor.author | Chan, SKW | en_HK |
dc.contributor.author | Chen, EYH | en_HK |
dc.date.accessioned | 2012-05-23T05:49:16Z | - |
dc.date.available | 2012-05-23T05:49:16Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Schizophrenia Research, 2011, v. 133 n. 1-3, p. 22-28 | en_HK |
dc.identifier.issn | 0920-9964 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/146905 | - |
dc.description.abstract | Background: Negative symptoms are a core feature of schizophrenia. The evolution and trajectory of primary negative symptoms were under-studied. We aimed at evaluating the prevalence and stability of primary negative symptoms, and factors associated with persistent primary negative symptoms in a first-episode sample. Method: Ninety-three Hong Kong Chinese aged 18 to 55. years presenting with first-episode schizophrenia-spectrum disorder were studied. Data on premorbid adjustment, socio-demographics, and baseline clinical and cognitive profiles were obtained. Psychopathological and vocational reassessments were conducted at 12, 24 and 36. months. Primary negative symptoms were defined as the presence of clinically significant negative symptoms excluding depression and extra-pyramidal signs. Results: At baseline, 25.8% of subjects exhibited primary negative symptoms. A quarter of patients had their initial primary negative symptoms status retained 12. months after treatment initiation. In both Year 2 and Year 3 of study period, around 70% of subjects had their primary negative symptoms status maintained for 12. months. At the end of three-year follow-up, 23.7% were categorized as having persistent primary negative symptoms. Male sex, unemployment at intake, prolonged duration of untreated psychosis, poorer premorbid academic and social functioning, poorer insight and worse vocational outcome were found to be associated with persistent primary negative symptoms. Conclusion: Clinical status of primary negative symptoms in first-episode schizophrenia-spectrum disorder was unstable in the initial year of treatment. Baseline symptom assessment may not reliably predict development of persistent primary negative symptoms. Studying negative symptoms should take into account the longitudinal perspective, especially in the early course of psychotic disorders. © 2011 Elsevier B.V. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/schres | en_HK |
dc.relation.ispartof | Schizophrenia Research | en_HK |
dc.subject | Course | en_HK |
dc.subject | First-episode schizophrenia | en_HK |
dc.subject | Outcome | en_HK |
dc.subject | Persistent primary negative symptoms | en_HK |
dc.subject | Stability | en_HK |
dc.subject.mesh | Behavioral Symptoms - etiology - psychology - therapy | - |
dc.subject.mesh | Predictive Value of Tests | - |
dc.subject.mesh | Psychiatric Status Rating Scales | - |
dc.subject.mesh | Schizophrenia - complications - diagnosis - epidemiology - therapy | - |
dc.subject.mesh | Schizophrenic Psychology | - |
dc.title | Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Chang, WC: changwc@hku.hk | en_HK |
dc.identifier.email | Lam, MML: maylam11@hku.hk | en_HK |
dc.identifier.email | Chen, EYH: eyhchen@hku.hk | en_HK |
dc.identifier.authority | Chang, WC=rp01465 | en_HK |
dc.identifier.authority | Lam, MML=rp00296 | en_HK |
dc.identifier.authority | Chen, EYH=rp00392 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.schres.2011.09.006 | en_HK |
dc.identifier.pmid | 21968080 | - |
dc.identifier.scopus | eid_2-s2.0-81955167927 | en_HK |
dc.identifier.hkuros | 199750 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-81955167927&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 133 | en_HK |
dc.identifier.issue | 1-3 | en_HK |
dc.identifier.spage | 22 | en_HK |
dc.identifier.epage | 28 | en_HK |
dc.identifier.eissn | 1573-2509 | - |
dc.identifier.isi | WOS:000298512500005 | - |
dc.publisher.place | Netherlands | en_HK |
dc.identifier.scopusauthorid | Chang, WC=26643706700 | en_HK |
dc.identifier.scopusauthorid | Hui, CLM=35734149500 | en_HK |
dc.identifier.scopusauthorid | Tang, JYM=35086815700 | en_HK |
dc.identifier.scopusauthorid | Wong, GHY=24465754400 | en_HK |
dc.identifier.scopusauthorid | Lam, MML=13106178700 | en_HK |
dc.identifier.scopusauthorid | Chan, SKW=55039018700 | en_HK |
dc.identifier.scopusauthorid | Chen, EYH=7402315729 | en_HK |
dc.identifier.citeulike | 9858097 | - |
dc.identifier.issnl | 0920-9964 | - |